“To Conquer Cancer with Light” — Minami M., President of Rakuten Medical, shares how the company’s Alluminox™ photoimmunotherapy is redefining head and neck cancer care. ASP-1929, already approved in Japan, is now in global Phase 3 trials—including Taiwan—targeting U.S. FDA approval by 2028. Beyond this minimally invasive therapy, Rakuten Medical is advancing RM-1995 for liver metastases and RM-0256 for solid tumors like skin and breast cancer, broadening its mission to conquer cancer with treatments that preserve dignity, restore function, and improve quality of life worldwide.
Read the full exclusive interview here in English: https://bit.ly/4ot15zX
Also available in Chinese: https://shorturl.at/BnVOy
Visit our YouTube to watch the full interview : https://lnkd.in/gTswAaNS
